Clinical Neurology and Neurosurgery
Volume 109, Issue 10 , Pages 926-930 , December 2007

Neuromyelitis optica in a patient with an early onset demyelinating episode: Clinical and autoantibody findings

  • Anja-Maria Beyer

      Affiliations

    • Department of Neurology, Charité-University Medicine, Charitéplatz 1, 10117 Berlin, Germany
    • ,
  • Klaus-Peter Wandinger

      Affiliations

    • Department of Neurology, Charité-University Medicine, Charitéplatz 1, 10117 Berlin, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 30 450560212; fax: +49 30 450560972.
    • ,
  • Eberhard Siebert

      Affiliations

    • Department of Neuroradiology, Charité-University Medicine, Charitéplatz 1, 10117 Berlin, Germany
    • ,
  • Rolf Zschenderlein

      Affiliations

    • Department of Neurology, Charité-University Medicine, Charitéplatz 1, 10117 Berlin, Germany
    • ,
  • Juliane Klehmet

      Affiliations

    • Department of Neurology, Charité-University Medicine, Charitéplatz 1, 10117 Berlin, Germany

Received 12 June 2007 ,Revised 14 August 2007 ,Accepted 18 August 2007.

References 

  1. Wingerchuk DM, Hogancamp WF, O’Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999;53:1107–1114
  2. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66:1485–1489
  3. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364:2106–2112
  4. Jarius S, Franciotta D, Bergamaschi R, Wright H, Littleton E, Palace J, et al. NMO-IgG in the diagnosis of neuromyelitis optica. Neurology. 2007;68:1076–1077
  5. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005;202:473–477
  6. Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF, et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol. 2005;59:566–569
  7. Paul F, Jarius S, Aktas O, Bluthner M, Bauer O, Appelhans H, et al. Antibody to aquaporin-4 in the diagnosis of neuromyelitis optica. PLOS Med. 2007;4(4):e133;[Epub ahead of print]
  8. Poser CM, Brinar VV. The nature of multiple sclerosis. Clin Neurol Neurosurg. 2004;106:159–171
  9. Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 2002;125:1450–1461
  10. Storch MK, Stefferl A, Brehm U, Weissert R, Wallstrom E, Kerschensteiner M, et al. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol. 1998;8:681–694
  11. Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinshenker BG. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology. 2002;58:143–146
  12. Cree BAC, Lamb S, Morgan K, Chen A, Waubant E, Genain C. An open label study of the effects of rituximab in neuromyelitis optica. Neurology. 2005;64:1270–1272
  13. Brinar VV. Non-MS recurrent demyelinating diseases. Clin Neurol Neurosurg. 2004;3:197–210
  14. Cambridge G, Leandro MJ, Edwards JCW, Ehrenstein MR, Salden M, Bodman-Smith M, et al. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. Arthritis Rheum. 2003;48:2146–2154
  15. Lalive PH, MengeT , Barman I, Cree BA, Genain CP. Identification of new serum autoantibodies in neuromyelitis optica using protein microarrays. Neurology. 2006;67:176–177

PII: S0303-8467(07)00233-8

doi: 10.1016/j.clineuro.2007.08.018

Clinical Neurology and Neurosurgery
Volume 109, Issue 10 , Pages 926-930 , December 2007

Article Tools

* Image Usage & Resolution